Evidence map›Paper›PMID 19447603›Full record

ReviewCurrent opinion in genetics & development2009

Endocytic regulation of Notch signaling.

Mark E Fortini, David Bilder

Abstract readReview
In one paragraph

Review in Current opinion in genetics & development, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 106 papers.

0numbers the graph read from it
0cells of the map it votes in
106citing papers in PubMed
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

106 citing papers in PubMed, 173 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. New Mutations in the 5' Region of theJournal of developmental biology · 2022
    Article
  19. Article
  20. Article

46 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Mark E FortiniDepartment of Biochemistry and Molecular Biology, Thomas Jefferson University, 830 Bluemle Life Sciences Building, 233 South 10th Street, Philadelphia, PA 19107, USA. mark.fortini@jefferson.edu
David Bilder
Jefferson Institute · USUniversity of California, Berkeley · US

Funding

Regulation of Drosophila Epithelial PolarityR01GM068675 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI BILDER, DAVID · 2003 to 2017
$3.9M
Mechanisms of Drosophila Tumor SuppressionR01GM090150 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI BILDER, DAVID · 2010 to 2018
$2.0M
Trafficking and Proteolysis of Notch and Other Gamma-Secretase SubstratesR01GM087650 · NIGMS · THOMAS JEFFERSON UNIVERSITY · PI FORTINI, MARK E · 2009 to 2012
$1.3M
NIGMS NIH HHS 1R01GM087650NIGMS NIH HHS R01 GM068675NIGMS NIH HHS R01GM068675NIGMS NIH HHS R01 GM087650NIGMS NIH HHS R01 GM090150
6 · The paper itself

Abstract

Endocytosis and endosomal trafficking have emerged as important cell biological steps in the Notch developmental signaling pathway. Ligand endocytosis helps generate the physical forces needed to dissociate and activate the receptor, and activated receptors enter endosomes to signal productively. Endosomal trafficking is also responsible for downregulating Notch receptors that have not been activated by ligand. Recent studies have provided new insights into these Notch trafficking steps, and have uncovered additional endosomal mechanisms that contribute to asymmetric Notch activation and ligand-independent Notch signaling.

Indexed as

AnimalsEndocytosisEndosomesModels, BiologicalProtein TransportReceptors, NotchSignal TransductionReceptors, Notch

Identifiers

PMID19447603
PMCPMC2731830
OpenAlexW2058693333

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.